Brijesh Kumar Author & Editor

Dr. Brijesh Kumar is a retired Professor (AcSIR) and Chief Scientist of Sophisticated Analytical Instrument Facility (SAIF) Division, CSIR-Central Drug Research Institute (CDRI), Lucknow, India. He has completed his M. Sc. from Lucknow University and Ph.D from CSIR-CDRI, Lucknow (Dr. Ram. Manohar. Lohia, Avadh University, Faizabad, UP, India). He has to his credit 7 books, 11 book chapters and 147 papers in reputed international journals. His area of research includes applications of mass spectrometry for qualitative and quantitative analysis of molecules for quality control and authentication/standardization of medicinal plants/parts and their herbal formulations

Vikas Bajpai completed his PhD from the Academy of Scientific and Innovative Research (AcSIR), New Delhi, India and carried his research work under supervision of Dr. Brijesh Kumar at CSIR-Central Drug research Institute Lucknow. His research includes development and validation of LC-MS/MS methods for qualitative and quantitative analysis of small molecules of Indian medicinal plants.

Mr. Vikas Kumar Gond is research fellow worked under supervision of Dr. Brijesh Kumar in mass spectrometry laboratory, sophisticated Analytical Instrument Facility at CSIR-Central Drug research Institute, Lucknow. He completed his masters in pharmaceutical chemistry from university of Lucknow. His research includes fingerprinting and characterization of phytopharmaceuticals using LC-MS/MS methods for qualitative and quantitative screening.

Dr. Subhashis Pal is a biologist, born in 1987 in Kolkata, India. He obtained his doctoral degree in 2019 specializing in Endocrinology and bone biology from Jawaharlal Nehru University, Delhi, India. During his Ph.D. tenure, he worked in Central Drug Research Institute, Lucknow, India on the potential bone anabolic role of phosphodiesterase inhibitors. Dr Pal joined Emory University, Atlanta, USA as staff research associate and currently working at Emory University with the effect of gut microbiome on bone health.

Dr. Naibedya Chattopadhyay is a Chief Scientist at CSIR-Central Drug Research Institute. His areas of research are endocrine pharmacology and metabolic bone diseases. Dr. Chattopadhyay has published >200 research articles and 9 patents out of which 5 are licensed to industries.